To hear about similar clinical trials, please enter your email below

Trial Title: Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

NCT ID: NCT05640999

Condition: Endometrial Cancer

Conditions: Official terms:
Endometrial Neoplasms

Study type: Interventional

Study phase: Phase 2

Overall status: Recruiting

Study design:

Allocation: Non-Randomized

Intervention model: Parallel Assignment

Primary purpose: Treatment

Masking: None (Open Label)

Intervention:

Intervention type: Radiation
Intervention name: Vaginal brachytherapy
Description: Vaginal brachytherapy should be delivered using a vaginal cylinder, or alternatively ovoids
Arm group label: Sub-Study B: TAPER

Intervention type: Radiation
Intervention name: Adjuvant radiotherapy (EBRT +/- brachytherapy)
Description: Treatment is to be delivered using 4-18 MV photons. MV, kV or CBCT imaging capabilities are required. Planning systems with capability for DICOM data transfer must be used.
Arm group label: Sub-Study A: RAINBO BLUE Cohort A2 Exploratory

Intervention type: Other
Intervention name: Observation
Description: Observation
Arm group label: Sub-Study A: RAINBO BLUE Cohort A2 Exploratory
Arm group label: Sub-Study B: TAPER
Arm group label: Sub-study A: RAINBO BLUE Cohort A1

Summary: This protocol tests de-escalated adjuvant treatment in patients with POLE-mutated or p53wt/NSMP (p53 wildtype/no specific molecular profile) early-stage endometrial cancer (EC). Patients may be enrolled in one of two sub-studies - EN10.A/RAINBO BLUE: POLE-mutated EC - EN10.B/TAPER: p53 wildtype / NSMP EC

Detailed description: This study is being done in order to find out if this new approach is better or worse than the usual approach for early-stage endometrial cancer. The usual approach is defined as the care most people get for early-stage endometrial cancer. The usual approach for patients who are not in a study is treatment with surgery. Tissue that is removed as part of this procedure is analyzed in the pathology laboratory to guide the doctor to decide whether or not additional treatment such as radiation and or chemotherapy should be recommended.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Patients must have had surgery consisting of hysterectomy and bilateral salpingo-oophorectomy. Lymph node dissection can be performed as per institutional standards. There must be no macroscopic residual disease after surgery. - Patients must have histologically confirmed Stage I to III endometrial carcinoma which can be endometrioid, serous, clear cell, un/dedifferentiated, carcinosarcoma or mixed. - Patients' Eastern Cooperative Group (ECOG) performance status must be 0, 1, or 2. - HIV-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial. - Patients' age must be ≥ 18 years. - Patient consent must be appropriately obtained in accordance with applicable local and regulatory requirements. - Patient is able (i.e. sufficiently fluent) and willing to complete the patient-reported outcomes (PRO) questionnaires in either English, French or a validated language - Patients must be accessible for treatment and follow-up. Patients enrolled on this trial must be treated and followed at the participating centre - Protocol treatment is to begin within 10 weeks of hysterectomy/bilateral salpingo-oophorectomy Exclusion Criteria: - Prior Neoadjuvant chemotherapy for current endometrial cancer diagnosis. - Prior pelvic radiation. - Patients with a history of other malignancies, except: adequately treated non-melanoma skin cancer, curatively treated in-situ cancer of the cervix, or other solid tumours curatively treated with no evidence of disease for ≥ 5 years. - Clinical evidence of distant metastasis as determined by pre-surgical or post-surgical imaging (CT scan of chest, abdomen and pelvis or whole-body PET-CT scan) (

Gender: Female

Gender based: Yes

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: UCHealth University of Colorado Hospital

Address:
City: Aurora
Zip: 80045
Country: United States

Status: Recruiting

Contact:
Last name: Bradley Corr

Facility:
Name: UMass Memorial Medical Centre

Address:
City: Worcester
Zip: 01605
Country: United States

Status: Recruiting

Contact:
Last name: Susan Zweizig

Phone: 508-856-6265

Facility:
Name: Sidney Kimmel Cancer Center Washington Township

Address:
City: Sewell
Zip: 08080
Country: United States

Status: Not yet recruiting

Contact:
Last name: Mitchell Edelson

Phone: 215-481-4000

Facility:
Name: Duke University Medical Center

Address:
City: Durham
Zip: 27710
Country: United States

Status: Recruiting

Contact:
Last name: Angeles Secord

Facility:
Name: University of Oklahoma Health Sciences Center

Address:
City: Oklahoma City
Zip: 73104
Country: United States

Status: Recruiting

Contact:
Last name: Christina Washington

Phone: 405-271-8777

Facility:
Name: Thomas Jefferson University

Address:
City: Philadelphia
Zip: 19107
Country: United States

Status: Not yet recruiting

Contact:
Last name: Mitchell Edelson

Phone: 215-481-4000

Facility:
Name: Asplundh Cancer Pavilion

Address:
City: Willow Grove
Zip: 19090
Country: United States

Status: Not yet recruiting

Contact:
Last name: Mitchell Edelson

Phone: 215-481-4000

Facility:
Name: Women and Infants Hospital

Address:
City: Providence
Zip: 02905
Country: United States

Status: Not yet recruiting

Contact:
Last name: Matthew Oliver

Phone: 401-274-1122

Phone ext: 48181

Facility:
Name: University of Utah Sugarhouse Health Centre

Address:
City: Salt Lake City
Zip: 84106
Country: United States

Status: Recruiting

Contact:
Last name: Cristina DeCesaris

Facility:
Name: Huntsman Cancer Institute University of Utah

Address:
City: Salt Lake City
Zip: 84112
Country: United States

Status: Recruiting

Contact:
Last name: Cristina DeCesaris

Facility:
Name: South Western Sydney Local Health District

Address:
City: Liverpool
Zip: 2170
Country: Australia

Status: Recruiting

Contact:
Last name: Viet Do

Facility:
Name: Westmead Hospital

Address:
City: Westmead
Zip: 2145
Country: Australia

Status: Recruiting

Contact:
Last name: Alison Brand

Facility:
Name: Mater Research Institute South Brisbane

Address:
City: South Brisbane
Zip: 4101
Country: Australia

Status: Recruiting

Contact:
Last name: Nimithri Cabraal

Facility:
Name: Monash Medical Centre

Address:
City: Clayton
Zip: 3168
Country: Australia

Status: Recruiting

Contact:
Last name: Shih-Ern Yao

Phone: 39 594-6666

Facility:
Name: Frankston Hospital

Address:
City: Frankston
Zip: 3199
Country: Australia

Status: Recruiting

Contact:
Last name: Yoland Antill

Facility:
Name: The Royal Women's Hospital

Address:
City: Parkville
Zip: 3053
Country: Australia

Status: Recruiting

Contact:
Last name: Orla McNally

Phone: 613 834-5356

Phone ext: 2

Facility:
Name: Canberra Hospital

Address:
City: Garran
Zip: ACT 2605
Country: Australia

Status: Recruiting

Contact:
Last name: Andrew Douglas Lee

Facility:
Name: Royal Brisbane and Womens Hospital

Address:
City: Herston
Zip: 4029
Country: Australia

Status: Recruiting

Contact:
Last name: Andrea Garrett

Phone: 73 646-8111

Facility:
Name: Tom Baker Cancer Centre

Address:
City: Calgary
Zip: T2N 4N2
Country: Canada

Status: Recruiting

Contact:
Last name: Tien Phan

Phone: 403 521-3926

Facility:
Name: Cross Cancer Institute

Address:
City: Edmonton
Zip: T6G 1Z2
Country: Canada

Status: Recruiting

Contact:
Last name: Fleur Huang

Phone: 780 432-8516

Facility:
Name: BCCA - Kelowna

Address:
City: Kelowna
Zip: V1Y 5L3
Country: Canada

Status: Recruiting

Contact:
Last name: Hamid Raziee

Facility:
Name: BCCA - Prince George

Address:
City: Prince George
Zip: V2M 7E9
Country: Canada

Status: Recruiting

Contact:
Last name: Allison Ye

Phone: 250 645-7300

Facility:
Name: BCCA - Vancouver

Address:
City: Vancouver
Zip: V5Z 4E6
Country: Canada

Status: Recruiting

Contact:
Last name: Jessica McAlpine

Phone: 604 877-6000

Phone ext: 2395

Facility:
Name: BCCA - Victoria

Address:
City: Victoria
Zip: V8R 6V5
Country: Canada

Status: Recruiting

Contact:
Last name: Caroline Holloway

Phone: 250 519-5609

Facility:
Name: Verspeeten Family Cancer Centre

Address:
City: London
Zip: N6A 5W9
Country: Canada

Status: Recruiting

Contact:
Last name: Lucas Mendez

Phone: 519 685-8600

Phone ext: 53169

Facility:
Name: Trillium Health Partners - Credit Valley Hospital

Address:
City: Mississauga
Zip: L5M 2N1
Country: Canada

Status: Recruiting

Contact:
Last name: Katherine Pulman

Phone: 905 813-1100

Phone ext: 1841

Facility:
Name: Odette Cancer Centre

Address:
City: Toronto
Zip: M4N 3M5
Country: Canada

Status: Recruiting

Contact:
Last name: Helen MacKay

Phone: 416 480-5145

Facility:
Name: University Health Network

Address:
City: Toronto
Zip: M5G 2M9
Country: Canada

Status: Recruiting

Contact:
Last name: Kathy Han

Phone: 416 946-4501

Phone ext: 2919

Facility:
Name: CHUM-Centre Hospitalier de l'Universite de Montreal

Address:
City: Montreal
Zip: H2X 3E4
Country: Canada

Status: Recruiting

Contact:
Last name: Maroie Barkati

Phone: 514 890-8254

Facility:
Name: The Jewish General Hospital

Address:
City: Montreal
Zip: H3T 1E2
Country: Canada

Status: Recruiting

Contact:
Last name: Susie K.S. Lau

Phone: 514 340-8222

Phone ext: 3114

Facility:
Name: CIUSSS de l'Estrie - Centre hospitalier

Address:
City: Sherbrooke
Zip: J1H 5N4
Country: Canada

Status: Recruiting

Contact:
Last name: Mathieu Viau

Facility:
Name: European Institute of Oncology

Address:
City: Milan
Zip: 20141
Country: Italy

Status: Recruiting

Contact:
Last name: Ilaria Betella

Phone: 39 025-7489

Facility:
Name: Radiotherapiegroep

Address:
City: Arnhem
Zip: 6815AD
Country: Netherlands

Status: Recruiting

Contact:
Last name: Dorien Haverkort

Phone: 318 877-9000

Facility:
Name: Maastro clinic (Maastricht UMC)

Address:
City: Maastricht
Zip: 6229ET
Country: Netherlands

Status: Recruiting

Contact:
Last name: Nienke Kuijsters

Phone: 31 088-4456

Phone ext: 0

Facility:
Name: Catharina ziekenhuis

Address:
City: Eindhoven
Zip: 5623 EJ
Country: Netherlands

Status: Recruiting

Contact:
Last name: Bastiaan Wortman

Phone: 40 239-9111

Facility:
Name: Erasmus Medical Center (EMC)

Address:
City: Rotterdam
Country: Netherlands

Status: Recruiting

Contact:
Last name: Henrieke Westerveld

Facility:
Name: Leiden University Medical Center (LUMC)

Address:
City: Leiden
Zip: 2333ZA
Country: Netherlands

Status: Recruiting

Contact:
Last name: Stephanie De Boer

Facility:
Name: Christchurch Hospital

Address:
City: Christchurch
Zip: 8140
Country: New Zealand

Status: Recruiting

Contact:
Last name: Bryony Simcock

Start date: December 19, 2022

Completion date: June 30, 2029

Lead sponsor:
Agency: Canadian Cancer Trials Group
Agency class: Other

Collaborator:
Agency: Canadian Cancer Clinical Trials Network
Agency class: Other

Source: Canadian Cancer Trials Group

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05640999

Login to your account

Did you forget your password?